Search research articles
Contact Us
Filters
Showing results (701-710 of 725) with videos related to
Page
of 73
Sort By:
JACC. Basic to Translational Science
|
January 8, 2020
Preservation of Post-Infarction Cardiac Structure and Function via Long-Term Oral Formyl Peptide Receptor Agonist Treatment
Ricardo A García, Bruce R Ito, John A Lupisella, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 11, 2021
The temporal onset of the core features in dementia with Lewy bodies
Parichita Choudhury, Jonathan Graff-Radford, Jeremiah A Aakre, et al.
Biorxiv : the Preprint Server for Biology
|
June 6, 2025
Repurposing Romidepsin for Osteosarcoma: Screening FDA-Approved Oncology Drugs with Three-Dimensional Osteosarcoma Spheroids
Emily E Seiden, Spencer M Richardson, Leah A Everitt, et al.
Cancer Discovery
|
October 14, 2017
Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer
Scott Gettinger, Jungmin Choi, Katherine Hastings, et al.
Plos One
|
February 14, 2022
Identifying SARS-COV-2 infected patients through canine olfactive detection on axillary sweat samples; study of observed sensitivities and specificities within a group of trained dogs
Dominique Grandjean, Capucine Gallet, Clothilde Julien, et al.
Cancer Research Communications
|
September 15, 2025
Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for Osteosarcoma
Emily E Seiden, Spencer M Richardson, Leah A Everitt, et al.
Cancer Cell
|
August 4, 2023
Mammalian SWI/SNF chromatin remodeling complexes promote tyrosine kinase inhibitor resistance in EGFR-mutant lung cancer
Fernando J de Miguel, Claudia Gentile, William W Feng, et al.
Nature Communications
|
August 22, 2025
Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cells
Lisa Brunet, David Alexandre, Jiyoung Lee, et al.
Cancers
|
August 30, 2020
Systems Biology Approach Identifies Prognostic Signatures of Poor Overall Survival and Guides the Prioritization of Novel BET-CHK1 Combination Therapy for Osteosarcoma
Pankita H Pandya, Lijun Cheng, M Reza Saadatzadeh, et al.
JACC. Basic to Translational Science
|
September 1, 2021
Selective FPR2 Agonism Promotes a Proresolution Macrophage Phenotype and Improves Cardiac Structure-Function Post Myocardial Infarction
Ricardo A García, John A Lupisella, Bruce R Ito, et al.
Page
of 73
Search research articles
Search
Showing results (701-710 of 725) with videos related to
Sort By:
Page
of 73
JACC. Basic to Translational Science
|
January 8, 2020
Preservation of Post-Infarction Cardiac Structure and Function via Long-Term Oral Formyl Peptide Receptor Agonist Treatment
Ricardo A García, Bruce R Ito, John A Lupisella, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 11, 2021
The temporal onset of the core features in dementia with Lewy bodies
Parichita Choudhury, Jonathan Graff-Radford, Jeremiah A Aakre, et al.
Biorxiv : the Preprint Server for Biology
|
June 6, 2025
Repurposing Romidepsin for Osteosarcoma: Screening FDA-Approved Oncology Drugs with Three-Dimensional Osteosarcoma Spheroids
Emily E Seiden, Spencer M Richardson, Leah A Everitt, et al.
Cancer Discovery
|
October 14, 2017
Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer
Scott Gettinger, Jungmin Choi, Katherine Hastings, et al.
Plos One
|
February 14, 2022
Identifying SARS-COV-2 infected patients through canine olfactive detection on axillary sweat samples; study of observed sensitivities and specificities within a group of trained dogs
Dominique Grandjean, Capucine Gallet, Clothilde Julien, et al.
Cancer Research Communications
|
September 15, 2025
Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for Osteosarcoma
Emily E Seiden, Spencer M Richardson, Leah A Everitt, et al.
Cancer Cell
|
August 4, 2023
Mammalian SWI/SNF chromatin remodeling complexes promote tyrosine kinase inhibitor resistance in EGFR-mutant lung cancer
Fernando J de Miguel, Claudia Gentile, William W Feng, et al.
Nature Communications
|
August 22, 2025
Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cells
Lisa Brunet, David Alexandre, Jiyoung Lee, et al.
Cancers
|
August 30, 2020
Systems Biology Approach Identifies Prognostic Signatures of Poor Overall Survival and Guides the Prioritization of Novel BET-CHK1 Combination Therapy for Osteosarcoma
Pankita H Pandya, Lijun Cheng, M Reza Saadatzadeh, et al.
JACC. Basic to Translational Science
|
September 1, 2021
Selective FPR2 Agonism Promotes a Proresolution Macrophage Phenotype and Improves Cardiac Structure-Function Post Myocardial Infarction
Ricardo A García, John A Lupisella, Bruce R Ito, et al.
Page
of 73